Literature DB >> 21681553

Communication of BRCA1 and BRCA2 genetic test results to health care providers following genetic testing at a tertiary care center.

K Ready1, B K Arun, K M Schmeler, A Uyei, J K Litton, K H Lu, C C Sun, S K Peterson.   

Abstract

Individuals at high risk for hereditary cancers often receive genetic counseling and testing at tertiary care centers; however, they may receive care for long-term management of their cancer risk in community settings. Communication of genetic test results to health care providers outside of tertiary care settings can facilitate the long-term management of high risk individuals. This study assessed women's communication of BRCA1/BRCA2 genetic test results to health care providers outside of tertiary care settings (termed "outside" health care providers, or OHCPs) and women's perceptions regarding communication of results. Women (n = 312) who underwent BRCA1/BRCA2 genetic counseling and testing completed a questionnaire assessing whether or not they shared test results with OHCPs and perceptions regarding the communication of test results to OHCPs. Most (72%) shared genetic test results with OHCPs. Women with no personal history of cancer were more likely to have shared results compared to women with a personal history of cancer. Mutation status did not significantly predict sharing of genetic information. Most reported positive perceptions regarding the disclosure of genetic test results to OHCPs. The majority did not report any concerns about potential insurance discrimination (88%) and indicated that OHCPs were able to appropriately address their questions (81%). Although most women shared their genetic test results with OHCPs, those with a personal history of cancer may need further encouragement to share this information. Tertiary care centers should facilitate outreach and education with OHCPs in order to assure appropriate long-term cancer risk management for high risk populations.

Entities:  

Mesh:

Year:  2011        PMID: 21681553     DOI: 10.1007/s10689-011-9460-z

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  35 in total

1.  Genetics education for health professionals: a context.

Authors:  Joseph D McInerney
Journal:  J Genet Couns       Date:  2007-10-19       Impact factor: 2.537

2.  Reproductive and hormonal factors, and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: results from the International BRCA1/2 Carrier Cohort Study.

Authors:  Antonis C Antoniou; Matti Rookus; Nadine Andrieu; Richard Brohet; Jenny Chang-Claude; Susan Peock; Margaret Cook; D Gareth Evans; Rosalind Eeles; Catherine Nogues; Laurence Faivre; Paul Gesta; Flora E van Leeuwen; Margreet G E M Ausems; Ana Osorio; Trinidad Caldes; Jacques Simard; Jan Lubinski; Anne-Marie Gerdes; Edith Olah; Christine Fürhauser; Hakan Olsson; Brita Arver; Paolo Radice; Douglas F Easton; David E Goldgar
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-02-03       Impact factor: 4.254

3.  Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.

Authors:  H Meijers-Heijboer; B van Geel; W L van Putten; S C Henzen-Logmans; C Seynaeve; M B Menke-Pluymers; C C Bartels; L C Verhoog; A M van den Ouweland; M F Niermeijer; C T Brekelmans; J G Klijn
Journal:  N Engl J Med       Date:  2001-07-19       Impact factor: 91.245

4.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

Authors:  D Ford; D F Easton; M Stratton; S Narod; D Goldgar; P Devilee; D T Bishop; B Weber; G Lenoir; J Chang-Claude; H Sobol; M D Teare; J Struewing; A Arason; S Scherneck; J Peto; T R Rebbeck; P Tonin; S Neuhausen; R Barkardottir; J Eyfjord; H Lynch; B A Ponder; S A Gayther; M Zelada-Hedman
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

5.  Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.

Authors:  Anne Uyei; Susan K Peterson; Julie Erlichman; Kristine Broglio; Sandra Yekell; Kathkeen Schmeler; Karen Lu; Funda Meric-Bernstam; Chris Amos; Louise Strong; Banu Arun
Journal:  Cancer       Date:  2006-12-15       Impact factor: 6.860

6.  Primary care physicians' knowledge and attitudes towards genetic testing for breast-ovarian cancer predisposition.

Authors:  M Escher; A P Sappino
Journal:  Ann Oncol       Date:  2000-09       Impact factor: 32.976

7.  Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers.

Authors:  T R Rebbeck; A M Levin; A Eisen; C Snyder; P Watson; L Cannon-Albright; C Isaacs; O Olopade; J E Garber; A K Godwin; M B Daly; S A Narod; S L Neuhausen; H T Lynch; B L Weber
Journal:  J Natl Cancer Inst       Date:  1999-09-01       Impact factor: 13.506

8.  Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.

Authors:  Noah D Kauff; Jaya M Satagopan; Mark E Robson; Lauren Scheuer; Martee Hensley; Clifford A Hudis; Nathan A Ellis; Jeff Boyd; Patrick I Borgen; Richard R Barakat; Larry Norton; Mercedes Castiel; Khedoudja Nafa; Kenneth Offit
Journal:  N Engl J Med       Date:  2002-05-20       Impact factor: 91.245

9.  Attitudes of obstetrician-gynecologists toward DNA testing for a genetic susceptibility to breast cancer.

Authors:  P T Rowley; S Loader
Journal:  Obstet Gynecol       Date:  1996-10       Impact factor: 7.661

Review 10.  Efficacy of risk-reducing salpingo-oophorectomy in women with BRCA-1 and BRCA-2 mutations.

Authors:  Olufunmilayo I Olopade; Grazia Artioli
Journal:  Breast J       Date:  2004 Jan-Feb       Impact factor: 2.431

View more
  4 in total

1.  Prevalence and correlates of receiving and sharing high-penetrance cancer genetic test results: findings from the Health Information National Trends Survey.

Authors:  Jennifer M Taber; Christine Q Chang; Tram K Lam; Elizabeth M Gillanders; Jada G Hamilton; Sheri D Schully
Journal:  Public Health Genomics       Date:  2015       Impact factor: 2.000

2.  Public awareness of genetic nondiscrimination laws in four states and perceived importance of life insurance protections.

Authors:  Alicia A Parkman; Joan Foland; Beth Anderson; Debra Duquette; Holly Sobotka; Mary Lynn; Shelley Nottingham; William David Dotson; Katherine Kolor; Summer L Cox
Journal:  J Genet Couns       Date:  2014-09-23       Impact factor: 2.537

3.  Establishing a program for individuals at high risk for breast cancer.

Authors:  Fernando Cadiz; Henry M Kuerer; Julio Puga; Jamile Camacho; Eduardo Cunill; Banu Arun
Journal:  J Cancer       Date:  2013-07-01       Impact factor: 4.207

4.  Do Breast Cancer Patients Tested in the Oncology Care Setting Share BRCA Mutation Results with Family Members and Health Care Providers?

Authors:  Susan T Vadaparampil; Teri Malo; Cara de la Cruz; Juliette Christie
Journal:  J Cancer Epidemiol       Date:  2012-07-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.